Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders
Background: Anxiety disorders are common, associated with significant burden of disease, and have high levels of treatment resistance. Low-dose ketamine has been extensively studied in treatment-resistant depression, with fewer reports in treatment-resistant anxiety disorders. Aims: This systematic...
Main Authors: | Elizabeth Whittaker, Alisher R. Dadabayev, Sonalee A. Joshi, Paul Glue |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-12-01
|
Series: | Therapeutic Advances in Psychopharmacology |
Online Access: | https://doi.org/10.1177/20451253211056743 |
Similar Items
-
Low Dose Ketamine Infusion for Comorbid Posttraumatic Stress Disorder and Chronic Pain: A Randomized Double-Blind Clinical Trial
by: Alisher R. Dadabayev, et al.
Published: (2020-12-01) -
Right Frontal Theta: Is It a Response Biomarker for Ketamine’s Therapeutic Action in Anxiety Disorders?
by: Shabah M. Shadli, et al.
Published: (2022-07-01) -
Ketamine and neuroticism: a double-hit hypothesis of internalizing disorders
by: N. McNaughton, et al.
Published: (2020-01-01) -
Ketamine and psychotherapy for the treatment of psychiatric disorders: systematic review
by: Bess M. Kew, et al.
Published: (2023-05-01) -
Intravenous ketamine in refractory depression
by: Shivang Gandhi, et al.
Published: (2022-01-01)